Neonatal Lupus — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Recurrence 16–18%; serial fetal cardiac surveillance; established complete heart block usually permanent
The best answer is “Recurrence 16–18%; serial fetal cardiac surveillance; established complete heart block usually permanent”. Maternally transferred anti-Ro/SSA antibodies can recur after an affected child, so specialist fetal surveillance is needed. Non-cardiac neonatal lupus features settle as maternal antibody clears, whereas established complete heart block is permanent. The low recurrence figure and spontaneous resolution in the second option are incorrect; the isolated-antibody restriction in the final option is unsupported.
Reference: NHSGGC anti-Ro and anti-La neonatal guideline: https://www.clinicalguidelines.scot.nhs.uk/ggc-paediatric-guidelines/ggc-paediatric-guidelines/neonatology/anti-ro-anti-la-antibodies-guideline-for-the-management-of-babies-born-to-mothers-with-systemic-lupus-erythematosus-sle-and-other-autoimmune-disorders-698/